hae
ViroPharma Inc. (VPHM) and Lev Pharmaceuticals Inc. (LEVP.OB) Venture into a Multi-Million Merger to Expand Portfolios
Read the full article: http://blog.qualitystocks.net/?p=11207
Biopharmaceutical companies ViroPharma Inc. (Nasdaq: VPHM) and Lev Pharmaceuticals Inc. (OTCBB: LEVP) today announced a definitive merger agreement potentially worth $617.5 million to further joint efforts for the treatment of inflammatory diseases.
No ticker information available.
- Login or register to post comments
- Read more
- Email this page
Related Articles
- ViroPharma Inc. (VPHM) and Lev Pharmaceuticals Inc. (LEVP.OB) Venture into a Multi-Million Merger to Expand Portfolios
- Patient Access Solutions Inc. (PASO.OB) is “One to Watch”
- SGX Pharmaceuticals, Inc. (SGXP) Submits FDA Investigational New Drug Application
- Magic Formula Business Sector #2: Healthcare
- An Intuitive Investment? - Intuitive Surgical (ISRG) is Poised to Grow in 2008
